FRONTIER CAPITAL MANAGEMENT CO LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2021$4,581,000
-61.6%
179,806
-47.2%
0.04%
-58.6%
Q2 2021$11,922,000
-67.0%
340,432
-61.6%
0.09%
-68.1%
Q1 2021$36,117,000
+520.5%
886,300
+861.3%
0.27%
+425.0%
Q2 2020$5,821,000
+115.5%
92,201
+74.4%
0.05%
+73.3%
Q1 2020$2,701,000
-74.6%
52,859
-60.6%
0.03%
-62.0%
Q4 2019$10,652,000
+258.8%
134,000
+119.0%
0.08%
+243.5%
Q3 2019$2,969,000
-10.8%
61,184
-3.3%
0.02%
-8.0%
Q2 2019$3,328,000
-64.1%
63,268
-67.0%
0.02%
-62.7%
Q1 2018$9,268,000191,8900.07%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders